Compare JEF & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | JEF | BIRK |
|---|---|---|
| Founded | 1968 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.5B |
| IPO Year | 2014 | 2023 |
| Metric | JEF | BIRK |
|---|---|---|
| Price | $55.73 | $41.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | $61.40 | ★ $61.43 |
| AVG Volume (30 Days) | ★ 2.0M | 1.4M |
| Earning Date | 03-25-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.37% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $10,823,677,000.00 | N/A |
| Revenue This Year | $13.23 | $13.71 |
| Revenue Next Year | $10.25 | $14.30 |
| P/E Ratio | $79.40 | ★ $17.48 |
| Revenue Growth | ★ 2.93 | N/A |
| 52 Week Low | $35.53 | $31.33 |
| 52 Week High | $71.04 | $53.53 |
| Indicator | JEF | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 52.65 | 40.22 |
| Support Level | $51.39 | $37.57 |
| Resistance Level | $58.32 | $42.11 |
| Average True Range (ATR) | 1.73 | 1.83 |
| MACD | 0.27 | -0.54 |
| Stochastic Oscillator | 76.76 | 6.68 |
Jefferies Financial Group is a full-service investment banking and capital markets firm that was founded in 1962. After nearly 30 years of focusing on institutional trading services, it entered the investment banking industry in the early 1990s, which ultimately grew into the core business. In 2013, Jefferies merged with Leucadia, a manufacturing-focused holding company. Since the merger, Jefferies became the core of the combined business as the bulk of the legacy portfolio was sold off and the parent company was renamed to match the subsidiary. Within the investment banking landscape, Jefferies predominately serves the North American middle market and has captured considerable market share over the past decade.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.